Literature DB >> 9801740

Natural history of hay fever: a 23-year follow-up of college students.

W A Greisner1, R J Settipane, G A Settipane.   

Abstract

The purpose of this study is to examine the natural history of hay fever among former college students who were diagnosed with this disease either before or after their freshman year. The diagnosis of hay fever or seasonal allergic rhinitis was based on a history of watery, itchy eyes, rhinorrhea, and sneezing occurring for at least 2 consecutive years during the same seasonal period. A total of 738 former Brown University students (69% males and 31% females) who were evaluated and underwent skin testing during their freshman year completed a 23-year follow-up questionnaire inquiring of their history of allergies and asthma. The mean age of this group at the time of the follow-up study was 40 years. During the 23 years subsequent to the original study, 131 developed new hay fever in addition to the 175 who had hay fever as college freshman, totaling 306. At the time of the 23-year follow-up, improvement was noted by 84.8% (28/33) of those with hay fever onset 1-5 years, 63.6% (56/88) of those with onset 6-12 years, 55.6% (40/72) of those with onset 13-19 years, and 38.7% (41/106) of those with onset 20 years and older. Among those with an unknown age of onset, 42.9% (3/7) reported improvement of hay fever symptoms. The trend of increasing percentage of improvement with younger age of onset of hay fever is of statistical significance (p value of < 0.0001) using the chi-squared test for trend. A total of 54.9% (168/306) had noted improvement, of which 22.9% (70/306) reported being symptom free and 32.0% (98/306) reported being better but not symptom free. Of the remaining 45.1% (138/306), the hay fever was unchanged in 33.3% (102/306), worsened in 9.2% (28/306), and unknown in 2.6% (8/306). This study suggests that over a long period of time, hay fever symptoms will improve in the majority of individuals.

Entities:  

Mesh:

Year:  1998        PMID: 9801740     DOI: 10.2500/108854198778557728

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  8 in total

Review 1.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

2.  Hayfever--practical management issues.

Authors:  Andrew Ross; Douglas Fleming
Journal:  Br J Gen Pract       Date:  2004-06       Impact factor: 5.386

3.  Exposure to Alternaria alternata in US homes is associated with asthma symptoms.

Authors:  Päivi M Salo; Samuel J Arbes; Michelle Sever; Renee Jaramillo; Richard D Cohn; Stephanie J London; Darryl C Zeldin
Journal:  J Allergy Clin Immunol       Date:  2006-10       Impact factor: 10.793

4.  Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005-2006.

Authors:  Päivi M Salo; Agustin Calatroni; Peter J Gergen; Jane A Hoppin; Michelle L Sever; Renee Jaramillo; Samuel J Arbes; Darryl C Zeldin
Journal:  J Allergy Clin Immunol       Date:  2011-02-12       Impact factor: 10.793

Review 5.  Prevalence and differential diagnosis of chronic rhinitis.

Authors:  J W Georgitis
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.806

Review 6.  Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations.

Authors:  Linda Cox
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

Review 7.  Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood.

Authors:  Anoja W Gunaratne; Maria Makrides; Carmel T Collins
Journal:  Cochrane Database Syst Rev       Date:  2015-07-22

8.  Reliably estimating prevalences of atopic children: an epidemiological study in an extensive and representative primary care database.

Authors:  David H J Pols; Mark M J Nielen; Joke C Korevaar; Patrick J E Bindels; Arthur M Bohnen
Journal:  NPJ Prim Care Respir Med       Date:  2017-04-13       Impact factor: 2.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.